Trial intelligence / Profile preview

Shouhui Tongbian Capsule for prevention and treatment of postoperative gastrointestinal dysfunction after orthopedic surgery

ChiCTR2400083127Phase 4Recruiting

Sponsor
Fourth Medical Center of PLA General Hospital
Start
Apr 2024
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of shouhui tongbian in Postoperative gastrointestinal dysfunction (POGD) (2 arms), sponsored by Fourth Medical Center of PLA General Hospital. Primary endpoint: Time to first spontaneous bowel movement after surgery. Started Apr 2024; status: recruiting.

02

Drugs

shouhui tongbian
03

Conditions

Postoperative gastrointestinal dysfunction (POGD)

Beyond the preview

Go deeper on ChiCTR2400083127.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400083127.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call